ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

10.23 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Revenue 00000000
Cost of Revenue 1.1071.0320.9660.8970.9710.90.9
Gross Profit -1.107-1.032-0.966-0.897-0.97-1-0.9-0.9
Gross Profit Ratio 00000000
Reseach & Development Expenses 114.07285.17261.6856.85835.92122.84419.02619.126
General & Administrative Expenses 28.82325.60825.08722.01313.4225.7253.3453.415
Selling & Marketing Expenses 0000000-0.9
SG&A 28.82325.60825.08722.01313.4225.7253.3452.515
Other Expenses -1.107-1.032-0.9660-0.9700.2330
Operating Expenses 141.788109.74885.80178.87148.37328.56922.37121.641
Operating Income -142.895-110.78-91.767-78.871-74.186-28.569-22.371-22.541
Operating Income Ratio 00000000
Total Other Income Expenses Net 15.04810.0832.6450.1560.4831.6861.0080.512
Income Before Tax -127.847-100.697-89.122-78.715-73.703-26.883-21.363-22.029
Income Before Tax Ratio 00000000
Income Tax Expense 002.355-1.0380-1.39700
Net Income -127.847-100.697-89.122-78.715-73.703-26.883-21.363-22.029
Net Income Ratio 00000000
EPS -1.83-1.96-2.25-2.07-3.36-0.85-1.12-0.74
EPS Diluted -1.83-1.96-2.25-2.07-3.36-0.85-1.12-0.74
EBITDA -126.74-109.748-88.156-77.974-72.733-27.541-20.463-21.129
EBITDA Ratio 00000000